Natixis Abb Vie Inc. Transaction History

Natixis

$17.4 Billion
Q2 2024

A detailed history of Natixis transactions in Abb Vie Inc. stock. As of the latest transaction made, Natixis holds 644,787 shares of ABBV stock, worth $131 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares

644,787

Previous 167,904 284.02%

Holding current value

$131 Million

Previous $30.6 Million 261.71%

% of portfolio

0.64%

Previous 0.16%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $73.8 Million - $86.2 Million	476,883 Added 284.02%	644,787 $111 Million
Q1 2024 May 13, 2024	SELL	$159.82 - $182.1 $33.5 Million - $38.1 Million	-209,342 Reduced 55.49%	167,904 $30.6 Million
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $591,817 - $666,525	4,301 Added 1.15%	377,246 $58.5 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $16.6 Million - $19.2 Million	-124,215 Reduced 24.98%	372,945 $55.6 Million
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $13.2 Million - $16.4 Million	99,691 Added 25.08%	497,160 $67 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $29.4 Million - $33.8 Million	-203,222 Reduced 33.83%	397,469 $63.3 Million
Q4 2022 Feb 24, 2023	BUY	$138.31 - $165.87 $1.05 Million - $1.26 Million	7,572 Added 1.28%	600,691 $97.1 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $33.1 Million - $39.7 Million	239,334 Added 67.65%	593,119 $95.9 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $2.84 Million - $3.26 Million	-21,187 Reduced 5.65%	353,785 $47.6 Million
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $27.5 Million - $35 Million	199,803 Added 114.06%	374,972 $57.4 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $5.7 Million - $7.07 Million	43,151 Added 32.69%	175,169 $28.4 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $6.97 Million - $8.82 Million	-64,874 Reduced 32.95%	132,018 $17.7 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $49.3 Million - $56 Million	-463,295 Reduced 70.18%	196,892 $21.2 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $68.2 Million - $76 Million	648,217 Added 5415.35%	660,187 $74.4 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $127 Million - $140 Million	-1,245,414 Reduced 99.05%	11,970 $1.3 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $34.6 Million - $46.8 Million	430,416 Added 52.05%	1,257,384 $133 Million
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $46.5 Million - $54.6 Million	-541,177 Reduced 39.56%	826,968 $72.4 Million
Q2 2020 Aug 13, 2020	SELL	$73.37 - $98.18 $37 Million - $49.5 Million	-504,589 Reduced 26.94%	1,368,145 $134 Million
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $19.1 Million - $29 Million	296,731 Added 18.83%	1,872,734 $143 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $91 Million - $114 Million	1,261,124 Added 400.51%	1,576,003 $140 Million
Q3 2019 Nov 13, 2019	SELL	$62.98 - $75.72 $91.5 Million - $110 Million	-1,452,741 Reduced 82.19%	314,879 $23.8 Million
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $75 Million - $95.9 Million	1,141,797 Added 182.45%	1,767,620 $129 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $41.6 Million - $48.9 Million	538,860 Added 619.64%	625,823 $50 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $157 Million - $194 Million	-2,019,377 Reduced 95.87%	86,963 $7.92 Million
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $136 Million - $151 Million	1,528,976 Added 264.82%	2,106,340 $199 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $27.6 Million - $32.6 Million	306,883 Added 113.46%	577,364 $53 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $39.9 Million - $53.5 Million	-433,905 Reduced 61.6%	270,481 $25.3 Million
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $36.6 Million - $40.1 Million	408,654 Added 138.18%	704,386 $68.1 Million
Q3 2017 Nov 14, 2017	SELL	$69.85 - $89.22 $3.26 Million - $4.16 Million	-46,609 Reduced 13.61%	295,732 $26.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	342,341	342,341 $24.8 Million

Others Institutions Holding ABBV

# of Institutions

3,771

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.83M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $360B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.

Account